SIGN cutaneous melanoma guideline
Easy-to-read summary of SIGN’s guideline on the management of cutaneous melanoma in primary care.
Melanoma skin cancer incidence rates in the UK have increased by 360% since the late 1970s. Cutaneous melanoma carries a significant risk of metastasis if left to develop into advanced melanoma and is a major cause of skin cancer mortality. However, patients can be encouraged to avoid exposure to factors that increase their risk of developing melanoma and it can often be treated by surgery if recognised at an early stage.
This new Guidelines summary covers the prevention and diagnosis of cutaneous melanoma, as well as how to support patients in primary care.